Vaxigrip

BIOLOGICAL6 trials

Sponsors

GlaxoSmithKline, University of British Columbia, Brenda Coleman, The University of Hong Kong, Research Institute for Biological Safety Problems

Conditions

Elderly InfectionInfluenzaInfluenza VaccineInfluenza, HumanObesityPregnancy; InfectionToleranceVaccination Site Reactions (HT)

Phase 2

Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control

CompletedNCT00778895

GlaxoSmithKlineInfluenza

Start: 2008-11-10End: 2009-08-19Updated: 2018-08-17

Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)

CompletedNCT03016143

Research Institute for Biological Safety ProblemsInfluenza

Start: 2016-10-31End: 2016-12-31Updated: 2018-06-07

Phase 4

Comparison of 4 Influenza Vaccines in Seniors

CompletedNCT01368796

University of British ColumbiaInfluenza Vaccine

Start: 2011-07-31End: 2012-05-31Updated: 2015-04-15

A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine

CompletedNCT01665807

Brenda ColemanInfluenza, Vaccination Site Reactions (HT)

Start: 2012-09-30End: 2012-12-31Updated: 2017-04-19

Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults

The University of Hong KongInfluenza, Human

Start: 2013-10-31End: 2015-06-30Target: 100Updated: 2013-10-22

Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

Active, not recruitingNCT06286488

Medical University of WarsawElderly Infection, Influenza, Obesity +4

Start: 2020-09-15End: 2026-05-01Updated: 2024-03-01

Related Papers

Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.

2020-02-122 citations

Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.

2015-10-319 citations

Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).

2012-08-0763 citations

Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial.

2012-03-0128 citations